228 related articles for article (PubMed ID: 23320620)
1. Thymosin β4 protects C57BL/6 mice from bleomycin-induced damage in the lung.
Conte E; Genovese T; Gili E; Esposito E; Iemmolo M; Fruciano M; Fagone E; Pistorio MP; Crimi N; Cuzzocrea S; Vancheri C
Eur J Clin Invest; 2013 Mar; 43(3):309-15. PubMed ID: 23320620
[TBL] [Abstract][Full Text] [Related]
2. Thymosin β4 reduces IL-17-producing cells and IL-17 expression, and protects lungs from damage in bleomycin-treated mice.
Conte E; Iemmolo M; Fagone E; Gili E; Fruciano M; Genovese T; Esposito E; Cuzzocrea S; Vancheri C
Immunobiology; 2014 Jun; 219(6):425-31. PubMed ID: 24613476
[TBL] [Abstract][Full Text] [Related]
3. Preventive and therapeutic effects of thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis.
Conte E; Fagone E; Gili E; Fruciano M; Iemmolo M; Pistorio MP; Impellizzeri D; Cordaro M; Cuzzocrea S; Vancheri C
Oncotarget; 2016 Jun; 7(23):33841-54. PubMed ID: 27029074
[TBL] [Abstract][Full Text] [Related]
4. 16,16-Dimethyl prostaglandin E2 efficacy on prevention and protection from bleomycin-induced lung injury and fibrosis.
Failla M; Genovese T; Mazzon E; Fruciano M; Fagone E; Gili E; Barera A; La Rosa C; Conte E; Crimi N; Cuzzocrea S; Vancheri C
Am J Respir Cell Mol Biol; 2009 Jul; 41(1):50-8. PubMed ID: 19059888
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of thymosin β4 in a mouse model of lung fibrosis.
Conte E; Genovese T; Gili E; Esposito E; Iemmolo M; Fruciano M; Fagone E; Pistorio MP; Crimi N; Cuzzocrea S; Vancheri C
Ann N Y Acad Sci; 2012 Oct; 1269():69-73. PubMed ID: 23045972
[TBL] [Abstract][Full Text] [Related]
6. Effects of thymosin β4 and its N-terminal fragment Ac-SDKP on TGF-β-treated human lung fibroblasts and in the mouse model of bleomycin-induced lung fibrosis.
Conte E; Iemmolo M; Fruciano M; Fagone E; Gili E; Genovese T; Esposito E; Cuzzocrea S; Vancheri C
Expert Opin Biol Ther; 2015; 15 Suppl 1():S211-21. PubMed ID: 26098610
[TBL] [Abstract][Full Text] [Related]
7. Thymosin β4 Suppresses LPS-Induced Murine Lung Fibrosis by Attenuating Oxidative Injury and Alleviating Inflammation.
Tian Z; Yao N; Wang F; Ruan L
Inflammation; 2022 Feb; 45(1):59-73. PubMed ID: 34414534
[TBL] [Abstract][Full Text] [Related]
8. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
9. Mizoribine protects against bleomycin-induced lung injury.
Matsui K; Ueda H; Terada M; Azuma N; Okamura H; Sano H
Mod Rheumatol; 2010 Oct; 20(5):471-7. PubMed ID: 20490597
[TBL] [Abstract][Full Text] [Related]
10. Bleomycin-induced pulmonary fibrosis is attenuated by an antibody against KL-6.
Xu L; Yang D; Zhu S; Gu J; Ding F; Bian W; Rong Z; Shen C
Exp Lung Res; 2013 Aug; 39(6):241-8. PubMed ID: 23672275
[TBL] [Abstract][Full Text] [Related]
11. Exercise Improves Lung Inflammation, but Not Lung Remodeling and Mechanics in a Model of Bleomycin-Induced Lung Fibrosis.
El-Mafarjeh E; Martins GHC; Probst JJ; Santos-Dias A; Oliveira-Junior MC; de Barros MP; de Oliveira LVF; de Andrade LD; da Palma RK; Moraes-Ferreira R; de Camargo Hizume-Kunzler D; Bachi ALL; Vieira RP
Oxid Med Cell Longev; 2020; 2020():4302608. PubMed ID: 33123311
[TBL] [Abstract][Full Text] [Related]
12. (5R)-5-hydroxytriptolide (LLDT-8) protects against bleomycin-induced lung fibrosis in mice.
Ren YX; Zhou R; Tang W; Wang WH; Li YC; Yang YF; Zuo JP
Acta Pharmacol Sin; 2007 Apr; 28(4):518-25. PubMed ID: 17376291
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol alleviates bleomycin-induced lung injury in rats.
Sener G; Topaloğlu N; Sehirli AO; Ercan F; Gedik N
Pulm Pharmacol Ther; 2007; 20(6):642-9. PubMed ID: 17035056
[TBL] [Abstract][Full Text] [Related]
14. Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin-induced lung injury.
Cortijo J; Iranzo A; Milara X; Mata M; Cerdá-Nicolás M; Ruiz-Saurí A; Tenor H; Hatzelmann A; Morcillo EJ
Br J Pharmacol; 2009 Feb; 156(3):534-44. PubMed ID: 19154443
[TBL] [Abstract][Full Text] [Related]
15. The effect of suramin on bleomycin-induced lung injury.
Lossos IS; Izbicki G; Or R; Goldstein RH; Breuer R
Life Sci; 2000 Oct; 67(23):2873-81. PubMed ID: 11106002
[TBL] [Abstract][Full Text] [Related]
16. Vitamin E reduces bleomycin-induced lung fibrosis in mice: biochemical and morphological studies.
Kilinç C; Ozcan O; Karaöz E; Sunguroğlu K; Kutluay T; Karaca L
J Basic Clin Physiol Pharmacol; 1993; 4(3):249-69. PubMed ID: 8679519
[TBL] [Abstract][Full Text] [Related]
17. [Effects of antisense oligonucleotide to nuclear factor-kappaB on the development of bleomycin-induced pulmonary fibrosis and IL-4 expression therein: experiment with mice].
Zhang XY; Zhou Y; Liu WQ; Zhao L; Li SQ
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):195-9. PubMed ID: 17425852
[TBL] [Abstract][Full Text] [Related]
18. Oxymatrine attenuates bleomycin-induced pulmonary fibrosis in mice via the inhibition of inducible nitric oxide synthase expression and the TGF-β/Smad signaling pathway.
Liu L; Lu W; Ma Z; Li Z
Int J Mol Med; 2012 May; 29(5):815-22. PubMed ID: 22367596
[TBL] [Abstract][Full Text] [Related]
19. Human recombinant interferon-alpha2a and interferon-alphaA/D have different effects on bleomycin-induced lung injury.
Berkman N; Kremer S; Or R; Lossos IS; Christensen TG; Goldstein RH; Breuer R
Respiration; 2001; 68(2):169-77. PubMed ID: 11287832
[TBL] [Abstract][Full Text] [Related]
20. Exacerbation of bleomycin-induced injury and fibrosis by pneumonectomy in the residual lung of mice.
Kakizaki T; Kohno M; Watanabe M; Tajima A; Izumi Y; Miyasho T; Tasaka S; Fukunaga K; Maruyama I; Ishizaka A; Kobayashi K
J Surg Res; 2009 Jun; 154(2):336-44. PubMed ID: 19118846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]